The Role of Nonsteroidal Antiinflammatory Drugs and Cyclooxygenase-2 Inhibitors on Experimental Colitis

Show simple item record

dc.contributor.author Paiotti, Ana Paula Ribeiro [UNIFESP]
dc.contributor.author Marchi, Patricia [UNIFESP]
dc.contributor.author Miszputen, Sender Jankiel [UNIFESP]
dc.contributor.author Oshima, Celina Tizuko Fujiyama [UNIFESP]
dc.contributor.author Franco, Marcello Fabiano de [UNIFESP]
dc.contributor.author Ribeiro, Daniel Araki [UNIFESP]
dc.date.accessioned 2018-06-15T17:38:31Z
dc.date.available 2018-06-15T17:38:31Z
dc.date.issued 2012-05-01
dc.identifier http://iv.iiarjournals.org/content/26/3/381.full
dc.identifier.citation In Vivo. Athens: Int Inst Anticancer Research, v. 26, n. 3, p. 381-393, 2012.
dc.identifier.issn 0258-851X
dc.identifier.uri http://repositorio.unifesp.br/11600/43916
dc.description.abstract The nonsteroidal anti-inflammatory drugs (NSAIDs) have been widely used in the management of pain and inflammation. Unfortunately, they are associated with dose-dependent gastrointestinal (GI) adverse events ranging from dyspepsia to symptomatic and complicated ulcers. The mechanism of NSAID action is attributed to the cyclooxygenase (COX) inhibition. New anti-inflammatory drugs have been synthesized, such as selective COX-2 inhibitors, however, these drugs may present side effects, such as modification of the epithelial barrier. Inflammatory bowel disease (IBD) is a common chronic gastrointestinal disorder characterized by alternating periods of remission and active intestinal inflammation. A possible association between the use of NSAIDs and the relapse of IBD has been repeatedly suggested. For this reason, many studies are conducted with the use of COX-2 in experimental models. The objective of this review is to describe the role of NSAIDs and COX-2 inhibitors in different experimental models of colitis. We reviewed controlled trials, original articles, case reports and reviews. The role of selective inhibition of COX-2 in the inflammatory process and the course of experimental and human colitis is controversially discussed. In conclusion, the relative role of COX-2 selective inhibitors on human and experimental colitis remains to be explored. Thus, the use of COX-2 inhibitors in IBD should be considered with caution. en
dc.format.extent 381-393
dc.language.iso eng
dc.publisher Int Inst Anticancer Research
dc.relation.ispartof In Vivo
dc.rights Acesso aberto
dc.subject NSAIDs en
dc.subject COX-2 inhibitors en
dc.subject IBD en
dc.subject experimental colitis en
dc.subject cyclooxygenase en
dc.subject review en
dc.title The Role of Nonsteroidal Antiinflammatory Drugs and Cyclooxygenase-2 Inhibitors on Experimental Colitis en
dc.type Resenha
dc.contributor.institution Universidade Federal de São Paulo (UNIFESP)
dc.description.affiliation Univ Fed Sao Paulo, Dept Biosci, BR-11060001 Santos, SP, Brazil
dc.description.affiliation Univ Fed Sao Paulo, Dept Pathol, BR-11060001 Santos, SP, Brazil
dc.description.affiliation Univ Fed Sao Paulo, Div Gastroenterol, BR-11060001 Santos, SP, Brazil
dc.description.affiliationUnifesp Univ Fed Sao Paulo, Dept Biosci, BR-11060001 Santos, SP, Brazil
dc.description.affiliationUnifesp Univ Fed Sao Paulo, Dept Pathol, BR-11060001 Santos, SP, Brazil
dc.description.affiliationUnifesp Univ Fed Sao Paulo, Div Gastroenterol, BR-11060001 Santos, SP, Brazil
dc.description.source Web of Science
dc.identifier.wos WOS:000303351100006



File

File Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search


Browse

Statistics

My Account